Tag Archives: Aileron
Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32
Section 32, which invests in healthcare and life sciences companies with a technology component, has added a third managing partner. The small venture capital firm was started in San Diego about two years ago by Bill Maris, who, during his time at Google, founded and led its corporate venture capital arm, now part of parent […]
Posted in Boston blog main, Boston top stories, National blog main, San Diego, San Diego blog main, San Diego top stories | Tagged Aileron, Alector, Auris Health, Bill Maris, Biotech, Foundation Medicine, Fulcrum Therapeutics, Infinity Pharmaceuticals, Life Sciences, Mike Pellini, Millennium Pharmaceuticals, Section 32, Steve Kafka, Takeda, Thrive Earlier Detection, Venture Capital | Comments Off on Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32Xconomy Boston’s Top 10 Stories from Q3 2013: Editor’s Picks
Herpes, PowerBars, and IPOs. Apple, Amazon, and acoustics. What more can you ask? Well, we’ve seen them all around town in the past three months. It’s the end of the third quarter, and with that, I’d like to highlight my 10 favorite Xconomy Boston stories from the period. They are a mix of company profiles, […]
Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged Aileron, Amar Bose, amazon, apple, Biotech, Epizyme, Genocea, Harvard University, healthcare, Healthtech, innovation, IPOs, IT, Life Sciences, nuance, people, Quanttus, samsung, Siri, Software, startups, Tillman Gerngross, VC, Venture Capital, Warp Drive Bio | Comments Off on Xconomy Boston’s Top 10 Stories from Q3 2013: Editor’s PicksNew England’s Emerging Biotech Stars: An Xconomy Forum In Pictures
Hollywood may be famous for its movie stars, but the Boston area has its own crop of celebrities… in biotech, that is. We showcased which companies and entrepreneurs are the ones to watch this past Wednesday at our Xconomy Forum: New England’s Emerging Biotech Stars. Biogen Idec was a gracious event host—and provided some insightful […]
Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories, OLD Boston slideshow | Tagged Adimab, Aileron, Alexandria Real Estate Equities, Audience, Aveo Pharmaceuticals, Biogen Idec, Biotech, Center for the Advancement of Science in Space, Chip Clark, Cubist Pharmaceuticals, Dicerna, Doug Fambrough, Doug Williams, event-recap, events, Genocea, George Scangos, GlaxoSmithKline, Guard Dog Brand Development, Halloran Consulting Group, Jens Eckstein, Joanna Horobin, Joseph Yanchik, Julia Greenstein, Juvenile Diabetes Research Foundation, Karyopharm, Kelly Scientific Resources, Leukemia & Lymphoma Society, Louise Perkins, Mark Levin, MFA-Moody Famiglietti & Andronico, Michael Kauffman, Multiple Myeloma Research Foundation, networking, people, Rick Winneker, SR One, Syndax, Third Rock Ventures, Tillman Gerngross, Tuan Ha-Ngoc, Xconomy, Xconomy Forum New England's Emerging Biotech Stars | 1 CommentSee You Today at New England’s Emerging Biotech Stars***SOLD OUT***
We’re about to get going on this afternoon’s Xconomy Forum: New England’s Emerging Biotech Stars. But you still have a few hours to get your tickets. We have 8 left as of early this morning, which you can grab by clicking here. We have a stellar lineup of speakers planned, including Biogen Idec CEO George […]
Posted in Boston, Boston blog main, National blog main | Tagged Adimab, Aileron, Biogen, Biotech, Dicerna, Doug Williams, Genocea, George Scangos, Life Sciences, New England's Emerging Biotech Stars, startups, Syndax, Xconomy Forum | Comments Off on See You Today at New England’s Emerging Biotech Stars***SOLD OUT***Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation
Mark Levin co-founded Boston’s Third Rock Ventures in 2007 with the goal of funding life sciences discoveries through the Valley of Death—when early-stage startups are no longer eligible for federal grants but they haven’t progressed enough to attract the attention of VCs. Third Rock has launched and incubated eight startups, including Foundation Medicine, Warp Drive […]
Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged Adimab, Agios, Aileron, Aveo Pharmaceuticals, Biogen, Biogen Idec, Biotech, Celgene, Dicerna, Doug Williams, events, Foundation Medicine, Genentech, Genocea, George Scangos, Life Sciences, Mark Levin, New England's Emerging Biotech Stars, Sage Therapeutics, Sanofi, Syndax, Third Rock Ventures, Tuan Ha-Ngoc, Warp Drive Bio, Xconomy, Xconomy events, Xconomy Forum | Comments Off on Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech InnovationGenocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum
In 2010, biotech entrepreneur Chip Clark was looking for a new challenge after the company he co-founded, Vanda Pharmaceuticals in Washington, DC, completed a $200 million licensing deal with Novartis. When he was offered the opportunity to join Cambridge, MA-based vaccine developer Genocea Biosciences, he jumped. “I was acutely sensitive to the notion that the […]
Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged Adimab, Aileron, Biogen, Biogen Idec, Chip Clark, Dicerna, Doug Williams, events, Gates Foundation, Genocea, George Scangos, herpes simplex 2, Life Sciences, New England's Emerging Biotech Stars, people, Syndax, vaccines, Xconomy Forum | Comments Off on Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech ForumNew England’s Emerging Biotech Stars: The Agenda
We’re just a month away from our next big biotech event in Boston, New England’s Emerging Biotech Stars. We have a stellar lineup planned for this afternoon event, which will be held April 4 at Biogen Idec in Cambridge, MA. Today we’re rolling out the official agenda for this exciting half-day conference. We’ll hear from […]
Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories | Tagged Adimab, Aileron, Biogen Idec, Biotech, Boston Millennia Partners, Chip Clark, Dana Callow, Dicerna, Doug Fambrough, Doug Williams, events, Genocea, George Scangos, JDRF, Jens Eckstein, Joanna Horobin, Joseph Yanchik, Julia Greenstein, Juvenile Diabetes Research Foundation, Karyopharm, Life Sciences, Louise Perkins, Mark Levin, Michael Kauffman, MMRF, Multiple Myeloma Research Foundation, New England's Emerging Biotech Stars, people, SR One, Syndax, Third Rock Ventures, Tillman Gerngross, Xconomy events, Xconomy Forum New England's Emerging Biotech Stars | Comments Off on New England’s Emerging Biotech Stars: The AgendaNew England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event
The life sciences industry is booming in the Boston area. Witness some of our headlines just over the past few weeks: Flagship Ventures closed a $270 million fund to invest in new biotech companies; startups RaNA and Warp Drive Bio raised significant VC rounds; pharma giant Merck led a $10 million financing of diagnostics firm […]
Posted in Boston, Boston blog main, Boston top stories, National blog main | Tagged Adimab, Aileron, BIIB, Biogen Idec, Biotech, Chip Clark, Dana Callow, Dicerna, Doug Fambrough, events, Genocea, George Scangos, JDRF, Joanna Horobin, Joseph Yanchik, Life Sciences, Mark Levin, Multiple Myeloma Research Foundation, Syndax, Third Rock Ventures, Tillman Gerngross, Xconomy Forum New England's Emerging Biotech Stars | Comments Off on New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event2009’s Top 10 Private Equity Deals in Massachusetts: The List
Life sciences companies nabbed nine of the 10 largest private equity deals in the Boston area in 2009, a year when investors were called on to fund biotechs and medical devices companies in late stages of product development, according to a recent survey by Dow Jones VentureSource. The survey data indicate that private equity investors […]
Posted in Boston, Boston blog main, National blog main | Tagged A123System, Aileron, Aileron Therapeutics, Aveo Pharmaceuticals, BioVex, ConforMIS, deals, Dow Jones VentureSource, Epizyme, IPOs, Life Sciences, Proteon Therapeutics, startups, Still River Systems, Synageva BioPharma, VC, Virdante Pharmaceuticals | Comments Off on 2009’s Top 10 Private Equity Deals in Massachusetts: The ListAileron Develops New Class of Drugs To Go Where None Could Before
If Aileron Therapeutics is on the right track, it will turn “stapled peptides” into a biotech industry buzzword along the lines of RNA interference. The Cambridge, MA-based company says its technology, like RNAi, is starting to show in animal tests that it can work against diseases where conventional drugs don’t. This company, whose name is […]
Posted in Boston, Boston blog main, National blog main | Tagged Aileron, Amgen, Amylin Pharmaceuticals, Apple Tree Ventures, Atorvastatin, Biotech, Byetta, cancer, Dana-Farber Cancer Institute, Eli Lilly, Exenatide, Genentech, Harvard Medical School, Joe Yanchik, Life Sciences, Lipitor, Loren Walensky, Nature, Novartis, Peptides, Pfizer, RNAi, Stanley Korsmeyer | Comments Off on Aileron Develops New Class of Drugs To Go Where None Could BeforeArchives
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 2005
- October 2005
- September 2005
- August 2005
- July 2005
- June 2005
- May 2005
- April 2005
- March 2005
- February 2005
- January 2005
- December 2004
- September 2004
- June 2004
- May 2004
- March 2004
- February 2004
- January 2004
- December 2003
- June 2003
- May 2003
- March 9
Meta